Accurate diagnosis hinges on precise numbers. For thyroid hormones, reference ranges are defined in two parallel systems: conventional units (common in the US) and Système International (SI) units (standard globally). Free T4 is 0.8–1.8 ng/dL or 10.3–23.2 pmol/L; Total T4 is 5.0–12.0 µg/dL or 64.5–154.8 nmol/L; Total T3 is 80–180 ng/dL or 1.232–2.772 nmol/L; and sensitive TSH is 0.4–4.2 µIU/mL, which is identical to 0.4–4.2 mIU/L. Precise unit conversion is not a trivial backend calculation—it is the bedrock of immunoassay kit development, ensuring clinical traceability, defining the analytical measuring interval (AMI), and enabling accurate cross-platform reporting that every patient result can be trusted, anywhere in the world.
The surface question is about two sets of numbers. The deep need is about diagnostic integrity. For IVD kit developers, the reference ranges in ng/dL or pmol/L are more than just labels—they are calibration targets. A single misstep in unit conversion cascades into incorrect calibrator values, a shifted analytical measuring interval, and ultimately a clinical result that could lead to a wrong decision. Flawless unit conversion is the silent guarantor of international laboratory equivalence.
Understanding the Two Unit Systems
How Conventional and SI Units Differ
Conventional units typically express hormone concentration as mass per volume (e.g., ng/dL, µg/dL), while SI units express them as molar concentration (e.g., pmol/L, nmol/L). The conversion factor is fixed for each analyte based on its molecular weight. This means every lot of calibrator, every quality control sample, and every patient report must account for which side of the decimal point matters.
The primary reference ranges for thyroid analytes illustrate this dual expression exactly:
- Free T4 (FT4): 0.8–1.8 ng/dL (10.3–23.2 pmol/L)
- Total T4: 5.0–12.0 µg/dL (64.5–154.8 nmol/L)
- Total T3: 80–180 ng/dL (1.232–2.772 nmol/L)
- Sensitive TSH (sTSH): 0.4–4.2 µIU/mL (0.4–4.2 mIU/L)
TSH is a special case where the unit is based on bioactivity, not mass, so the numeric value is identical in both systems.
The Critical Role of Units in Defining the Analytical Measuring Interval
The analytical measuring interval (AMI) is the range of analyte concentrations an assay can measure with acceptable linearity and precision. AMI must be anchored to clinically relevant reference ranges. If developers calibrate against a master calibrator defined in ng/dL but report in SI units without rigorous conversion, the AMI boundaries will shift. This can inadvertently truncate the reportable range or, worse, expose the assay to inaccuracies at medical decision points.
The primary reference stresses that immunoassay raw materials—recombinant antigens, antibodies, and matrix-matched calibrators—must be validated against both unit systems. This ensures the AMI is consistent regardless of the reporting unit, a non-negotiable for global kits.
Why Unit Conversion Is the Hidden Foundation of IVD Kit Performance
Calibration Traceability Depends on Conversion Rigor
Every immunoassay kit relies on a calibration hierarchy that traces back to a reference standard. If that standard is certified in SI units, but the kit’s target customers use conventional units, the value assignment process must convert values flawlessly. A rounding error at the top propagates through the entire lot, affecting thousands of patient results.
The primary reference makes clear that this is central to clinical traceability. Matrix-matched calibrators—designed to behave like real patient samples—must be assigned values in both unit systems. This dual assignment is what lets a lab in Berlin and a lab in Boston report identical Free T4 results despite displaying different numerical units.
Cross-Platform Comparability and the AMH Warning Sign
The supplementary reference, while focused on anti-Müllerian hormone (AMH), provides a powerful cautionary tale. Historically, AMH lacked a universal reference standard, so different immunoassay kits produced different numerical values. The fix today includes a standardized conversion: 1 ng/mL = 7.14 pmol/L. Yet developers still must establish kit-specific reference ranges because antibody specificities differ.
For thyroid hormones, harmonization is more mature, but the lesson remains. Even with a standard conversion factor, assuming equivalence across platforms without validating unit conversion at the raw material level invites clinical misalignment. A Total T4 kit that reports in µg/dL but has an internal calibration drift because of poor unit mapping will yield results that are not comparable to a gold-standard method.
Avoiding the Most Common Unit Conversion Pitfalls
Molecular weight confusion. Using an incorrect molecular weight for the conversion turns a precise calculation into a systematic error. For example, T4 has a defined mass, and the factor must be applied identically across all calibrator levels.
Matrix effect neglect. A calibrator that reads correctly in buffer may show a slight shift in human serum. The conversion factor itself doesn’t change, but if the calibration curve is not verified in both unit systems in the relevant matrix, the reported SI value may be off.
Rounding at intermediate steps. Converting from ng/dL to pmol/L for FT4 requires careful handling of significant digits. An early roundoff can push an AMI boundary outside the clinical reference range, making a healthy patient’s result appear pathological.
Understanding the Trade-offs
Harmonization Is Not Yet Perfect
The primary and supplementary references both imply a fundamental truth: reference ranges are still method-dependent. Even with precise unit conversion, different antibody clones and detection technologies can yield slightly different absolute values for the same sample. This means kit developers cannot simply adopt published reference ranges as their own; they must establish kit-specific, unit-converted ranges verified in the target population.
The trade-off is between global standardization and local clinical utility. A perfectly converted SI range that does not reflect the kit’s analytical behavior is a liability. Developers must invest in bridging studies that validate the unit conversion and the range simultaneously.
Complexity vs. Usability
Designing a kit that reports in both units adds complexity to software, labeling, and quality control materials. However, omitting one unit system limits market access. The trade-off is manageable if the conversion is built into the assay’s foundational calibration protocols, not tacked on at the end.
Making the Right Choice for Your IVD Kit Development
Align your unit conversion strategy with your development goals and your end users.
- If your primary focus is global market access: Engineer your calibrators and master lot documentation to carry dual value assignments (conventional and SI). Validate your AMI in both unit systems using matrix-matched samples, and provide clear IFU (Instructions for Use) statements on the conversion factor used.
- If your primary focus is reference range accuracy: Conduct a dedicated range study in your target population, calculate the central 95% in both units using the exact conversion factor your kit employs. Never copy a published range without verifying it against your reagent system, no matter how precise the conversion math.
- If your primary focus is cross-platform comparability: Participate in external quality assessment schemes that report in both units. Use the results to fine-tune your calibrator value assignment, ensuring that any observed bias is not an artifact of unit conversion but of real immunological differences.
- If your primary focus is regulatory compliance: Document every step of the conversion process. Show how you derived your conversion factor from the analyte’s certified molecular weight, and demonstrate traceability to a recognized reference system. Auditors will scrutinize the link between your conventional-unit calibrator and its SI-unit pedigree.
In the end, precise unit conversion is not about moving a decimal point—it is about ensuring that a woman worried about her thyroid health gets the same reliable answer whether her blood is tested in Chicago or Copenhagen. That is the standard every IVD kit must meet.
Summary Table:
| Thyroid Analyte | Conventional Unit & Range | SI Unit & Range | IVD Development Impact |
|---|---|---|---|
| Free T4 (FT4) | 0.8–1.8 ng/dL | 10.3–23.2 pmol/L | Essential for setting AMI boundaries & medical decision points |
| Total T4 (TT4) | 5.0–12.0 µg/dL | 64.5–154.8 nmol/L | Requires accurate molecular weight math to avoid calibration drift |
| Total T3 (TT3) | 80–180 ng/dL | 1.232–2.772 nmol/L | Sensitive to intermediate rounding errors during master calibration |
| Sensitive TSH (sTSH) | 0.4–4.2 µIU/mL | 0.4–4.2 mIU/L | 1:1 bioactivity ratio; numeric values are identical across systems |
Build Globally Traceable Immunoassays with CamelBio
Achieving flawless calibration and clinical traceability requires raw materials and technical strategies engineered to perfection. CamelBio provides diagnostic manufacturers, clinical laboratories, and research institutes with one-stop access to premium IVD raw materials, technical services, and expert consulting—covering every stage from concept to clinic.
Whether you need high-affinity antibody pairs, validated recombinant antigens, or guidance on dual-unit value assignment for matrix-matched calibrators, our technical experts are here to help you eliminate risk and ensure cross-platform consistency.
Ready to enhance your assay accuracy and regulatory compliance? Contact CamelBio today to collaborate with our IVD specialists.